AI & Emerging Technology

The Spanish biotech firm strengthens its IP for a novel aggression treatment, targeting a growing multi-billion dollar Japanese CNS market.

As CFO Scott Ullem preps for a key presentation, Edwards balances record innovation and strong financials against new regulatory hurdles. What's at stake?

New data shows traveling to the Bay Area for the 2026 championship is far cheaper than last year, but local prices are still soaring for the big game.

With its stock under pressure, Insperity's upcoming Q4 earnings and 2026 outlook will be a critical test of its strategy to combat rising healthcare costs.

After a regulatory setback, Ultragenyx has resubmitted its BLA for UX111, a potential first-ever treatment for the devastating Sanfilippo syndrome type A.

With national security clearance secured, silicon carbide leader Wolfspeed completes its restructuring, forging a powerful alliance with Japan's Renesas.

COSRX makes history as the official hair sponsor for MISS SOHEE, marking a major milestone for K-beauty in the exclusive world of haute couture.

The 140-year-old industrial giant earns a coveted spot on Fortune's list, recognized for its innovation in smart buildings and sustainability leadership.

CIRM's new RAPID program aims to revolutionize genetic therapy, using scalable platforms to bring hope to millions with rare diseases who have no options.

With stronger Phase 2 data for its ATH434 drug and a healthy cash reserve, Alterity Therapeutics is preparing for a pivotal trial and seeking partners.

ADATA's new $10M investment values publisher 4Divinity at $250M, fueling a global push and a bold new strategy merging game IP with custom hardware.

A strategic merger combines a century of power engineering with modern controls, creating a new force for data centers and telecom infrastructure.

The O.H.I.O. Fund hits major milestones, luring a California construction-tech firm to Columbus and signaling a new era of industrial innovation.

The deal gives Demeetra sole control of the Super piggyBac platform, aiming to resolve IP hurdles and accelerate non-viral gene therapy development.

In a major strategic shift, Coleto Brands brings its two lighting powerhouses, Kichler and Progress, together for a unified, immersive experience at KBIS 2026.

Italian appliance giant defies market headwinds with 10.4% growth, fueled by its premium coffee strategy and a dual-pronged attack on home and pro markets.

Canada's largest game studio appoints a new COO and Deputy CEO, signaling a strategic evolution to manage its rapid expansion beyond Dead by Daylight.

A new partnership will leverage advanced technology to transform care for thousands of Medicare patients, aiming for better outcomes and lower costs.

Robotics pioneer Wandercraft adds med-tech veteran Chuck Witkowski to its board, a strategic move to commercialize its Eve exoskeleton and scale globally.

A repeat order for a robotic munitions production line signals BOS's growing influence in defense automation and highlights a global industry shift.